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Abstract
Cognitive fusion, or the degree to which a person is entangled with their thoughts and takes them literally, is considered a normal
yet detrimental cognitive process associated with diverse negative outcomes across healthy and disordered functioning, including
in fibromyalgia. Given the relevance of this cognitive process, the aim of the present study is to generate empirical evidence on
the reliability and validity of the Cognitive Fusion Questionnaire (CFQ) in a sample of Spanish females with fibromyalgia. In this
cross-sectional study, 230 Spanish females diagnosed with fibromyalgia (mean age 56.89 years; SD = 8.96) were assessed on
cognitive fusion, pain catastrophizing, personality traits, positive and negative affect, anxiety symptoms, depressive symptoms
and disease severity. Confirmatory factor analysis, reliability and validity analyses were performed. The CFQ showed a unidi-
mensional structure, adequate temporal stability and good internal consistency. In addition, convergent and discriminant validity
were found with respect to dispositional, pain-related, affective, mood and anxious measures; as well as incremental and criterion
validity in the prediction of psychological symptoms or the disease severity status. The CFQ has been revealed as a solid and
valid measure in the evaluation of cognitive fusion in Spanish females suffering from fibromyalgia, and may also be useful in
clinical contexts due to the relationships it has shown with important outcomes. Limitations and future directions are also
discussed.
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Introduction
Fibromyalgia (FM) is a chronic disorder characterized by per-
sistent and widespread musculoskeletal pain (Wolfe et al.,
1990, 2010, 2018) and several non-pain related symptoms,
such as fatigue, sleep problems and cognitive disturbances
(Häuser et al., 2015). This syndrome mainly affects females
(ranging from 61 to 90%) (Wolfe et al., 2018) and its preva-
lence has been estimated to be around 2–4% in the general
population (Wolfe et al., 2010). Regarding psychological as-
pects, estimates indicate that between 20 and 80% of FM
patients have comorbid affective disorders such as depression
and anxiety (Clauw, 2014). Thus, its physical and psycholog-
ical symptoms cause the disease to constitute both a burden
for patients and a public health problem that generates high
economic, social and health costs (Arnold et al., 2016;
Sicras-Mainar et al., 2009).
Cognitions have been shown to play a key role in adapta-
tion to chronic pain conditions (De Ridder et al., 2008).
Specifically, vulnerability factors such as pain catastrophizing
or protective resources like self-efficacy in pain management
have consistently demonstrated their relevance to the quality
of life of individuals with FM (Angarita-Osorio et al., 2019;
Estévez-López et al., 2018; Pulido-Martos et al., 2020).
However, as noted, pain is not the only symptom of FM
and there are some authors who have explored the role of other
cognitive variables of a general nature not exclusively linked
to pain. Thus, it has been found that variables such as low
frustration tolerance, self-deprecating style) (Suso-Ribera
et al., 2016) or ruminative thinking (Malin & Littlejohn,
2015) can act as vulnerability factors in patients experiencing
chronic pain conditions. In this vein, a cognitive variable that
is receiving increasing interest is cognitive fusion. This con-
struct, developed from acceptance and commitment therapy
(ACT) (Hayes et al., 2011), refers to the relationship a person
has with his or her own cognitions (Gillanders et al., 2014, p.
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84). Specifically, it is defined as the degree to which a person
thinks that the content of their thoughts fully reflects reality,
that is, to what extent people react to their own thoughts as if
they were an objective reality (Carvalho et al., 2018;
Gillanders et al., 2014; Romero-Moreno et al., 2014, p. 119).
Among the instruments for assessing cognitive fusion,
the Cognitive Fusion Questionnaire (CFQ) (Gillanders
et al., 2014) is the most widely used measure (Cincidda
et al., 2019). Psychometric properties of the CFQ Spanish
translation have proven satisfactory (Romero-Moreno
et al., 2014). Although there are other measures of cogni-
tive fusion in the Spanish population, both in non-clinical
(Ruiz et al., 2014; Valdivia-Salas et al., 2016) and in FM
populations (Rodero et al., 2013), to our knowledge, the
CFQ is the only one that evaluates this construct in a
general way (without focusing on cognitions about a spe-
cific topic, such as anxious cognitions or cognitions about
pain).
Angarita-Osorio et al. (2019) reported that cognitive fusion
is associated with poorer function in people with FM, though
that study used a pain specific measure of cognitive fusion.
Evidence is beginning to accumulate from studies using the
CFQ about the key role that this generic variable plays in
patients with various chronic pain conditions. In particular,
CFQ scores have been associated with pain intensity both in
patients without rheumatic disease (Özkan et al., 2017) and in
patients with heterogeneous chronic pain conditions
(Carvalho et al., 2018). Significant associations have also
been found between CFQ and pain catastrophizing in patients
with both FM (Écija et al., 2020) and without rheumatic dis-
ease (Özkan et al., 2017). In patients experiencing FM or
chronic pain conditions, cognitive fusion has also been linked
to lower vitality (McCracken et al., 2014), increased physical
fatigue (Écija et al., 2020) and poorer perceived general health
(McCracken et al., 2014). Cognitive fusion assessed with the
CFQ has also been related to anxious and depressed symp-
toms (McCracken et al., 2014) in cross-sectional (Écija et al.,
2020; Carvalho et al., 2018; McCracken et al., 2014) and
longitudinal studies (Carvalho et al., 2019). Additionally, al-
though there is no evidence in patients with FM or other rheu-
matic diseases, cognitive fusion has also been significantly
related to personality variables such as neuroticism
(Momeniarbat et al., 2017) and affective variables such as
positive and negative affect (Bolderston et al., 2019).
Given that cognitive fusion appears to be a detrimental
cognitive process linked to negative outcomes in patients with
FM (Carvalho et al., 2018, 2019; Écija et al., 2020), a solid
and valid instrument to assess this cognitive vulnerability fac-
tor would prove invaluable for research with FM population.
Currently, the CFQ is validated in Spain in a sample of care-
givers of relatives with dementia (Romero-Moreno et al.,
2014), but, to our knowledge, not with FM or other chronic
pain patients. Thus, the aim of the present study is to generate
empirical evidence on the reliability and validity of the CFQ in
a Spanish FM sample.
Method
Participants
In this study, 230 Spanish females with FM between the ages
of 30 and 78 (M = 56.89 years, SD = 8.96 years) were
evaluated on the variables of interest. Table 1 presents the
sociodemographic data and the clinical characteristics of the
participating females. Out of the 230 participants, 90 were
selected (by a random number generator) to reassess their
levels of cognitive fusion twomonths after the first evaluation,
Table 1 Study participants’ socio-demographic and clinical character-
istics (n = 230)
Age (30 to 78 years), mean (SD) 56.89 (8.96)
Level of education, n (%)
Unfinished primary education 30 (13.00)
Primary education 121 (52.60)
Secondary (and vocational) education 61 (26.50)
University education 15 (6.50)
Missing data 3 (1.30)
Marriage status, n (%)
Single 12 (5.20)
Married (or cohabiting together) 181 (78.70)
Divorced/separated 20 (8.70)
Widowed 16 (7.00)
Missing data 1 (0.40)
Employment situation, n (%)
Domestic work 76 (33.00)
Unemployed 28 (12.20)
Working 28 (12.20)
Pensioned not due to pain issues 32 (13.90)
Pensioned because of pain issues 41 (17.80)
Medical leave 23 (10.00)
Missing data 2 (0.90)
Years after diagnosis of FM (1 to 46), mean (SD) 12.10 (8.45)
Missing data 5 (2.20)
Antidepressant medication, n (%) 144 (62.60)
Missing data 13 (5.70)
Analgesic medication, n (%) 193 (83.90)
Missing data 9 (3.90)
Sleep medication, n (%) 129 (56.10)
Missing data 12 (5.20)
Muscle relaxant medication, n (%) 80 (34.80)
Missing data 18 (7.80)
SD Standard Deviation
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among them, 62 agreed and were finally reevaluated.
Participation in this study had three inclusion criteria: (i)
being older than 18 years of age; (ii) having a FM diag-
nosis based on the criteria established by the American
College of Rheumatology (ACR) (Wolfe et al., 1990,
2010); and (iii) giving written consent to participate in
the present research. The recruitment of participants took
place by contacting with pain support associations across
the country (Albacete, Toledo, Madrid, Ciudad Real, and
Guadalajara). This study obtained the approval of the Rey
Juan Carlos University Ethics Committee (reference code
PI-17/00858 and project number 160520165916) and
written informed consent for anonymous analysis of data
was retrieved from all participants. The ethical guidelines
for research with human participants of the Helsinki
Declaration were met.
Measures
Socio-demographic (i.e., age, level of education, marriage sta-
tus, and employment situation) and clinical variables (i.e.,
time since the diagnosis of FM, antidepressant medication,
analgesic medication, sleep medication, and muscle relaxants
intake) were evaluated using a questionnaire created for this
study.
Cognitive fusion was assessed using the Spanish version of
the CFQ developed by Romero-Moreno et al. (2014). The
instrument comprises seven items using a Likert-type re-
sponse format of seven points that ranges from 1 to 7.
Higher scores on this scale indicate a more marked cognitive
fusion. This measure contains items like “I get so caught up in
my thoughts that I am unable to do the things that I most want
to do” and the overall score ranges from 7 to 49. Cronbach’s
alpha of both the original version of the scale (.80 to .90 with
different samples) and the Spanish version (.87) was high in
both cases.
The Spanish validation developed by Garcia-Campayo
et al. (2008) of the Pain Catastrophizing Scale (PCS;
Sullivan et al., 1995) was used to assess the level of
catastrophizing with regard to pain, conceived as an excessive
pessimistic orientation in relation to present or anticipated
experiences of pain (Garcia-Campayo et al., 2008; Sullivan
et al., 1995, p. 524). This measure contains three subscales
that evaluate the three components of the construct: magnifi-
cation, rumination and helplessness. Magnification refers to
an overestimation regarding to the unpleasantness of painful
events and the expectations of experiencing adverse out-
comes; rumination relates to worry, ruminative thoughts,
and an inefficacy to inhibit thoughts related to pain; and help-
lessness includes negative evaluations regarding the ability to
efficiently handle pain stimuli (Sullivan et al., 1995, p. 525).
The instrument contains 13 items that use a Likert-type format
of four points, with high scores denoting a higher degree of
pain catastrophizing. The Spanish adaptation possess ade-
quate psychometric properties, reporting good reliability (in-
ternal consistency) for both the overall score (.79) and the
subscales (ranging between .74 and .82) (Garcia-Campayo
et al., 2008). Good internal consistency was found in this
study for both the total score (.94) and the subscales (.78 for
magnification, .87 for rumination and .89 for helplessness).
Personality traits were assessed by the Spanish valida-
tion of the NEO Five-Factor Inventory (NEO-FFI) devel-
oped by Seisdedos (1999), which includes 60 items using
a Likert-type response format of five points that evaluate
the five principal personality traits: neuroticism, extraver-
sion, conscientiousness, agreeableness, and openness.
Every single subscale or dimension can be scored be-
tween 0 and 48. Higher scores on the subscales reflect
more pronounced personality traits. The internal consis-
tency reported by the Spanish version was good
(Cronbach’s alphas ranging between .82 and .90)
(Seisdedos, 1999). In this study, reliability was good for
some traits (.83, .74, and .80 for neuroticism, extraversion
and conscientiousness, respectively) and acceptable to
low for others (.60 and .64 for openness and agreeable-
ness, respectively).
Depressive and anxious symptoms over the preceding
week were measured with the Spanish version of the
Hospital Anxiety and Depression Scale (HADS; Zigmond
& Snaith, 1983) (Herrero et al., 2003). The HADS is a 14
item measure with a Likert response format of four points,
designed to be used with non-psychiatric populations. The
depression and anxiety subscales each have 7 items, higher
scores represent higher depressive or anxious symptom-
atology. This measure, characterized by avoiding evaluat-
ing the somatic manifestations of emotional disorders in
order not to over-diagnose anxiety or depression in patients
suffering from physical conditions, has been specifically
validated in the Spanish population with FM (Luciano
et al., 2014a). The reliability reported by the authors of
the Spanish version was high for both subscales (.84 and
.85), as it was in the present study (.85 and .80).
Participants’ positive and negative affect levels were eval-
uated with the Spanish version of the Positive and Negative
Affect Schedule (PANAS) developed by Sandin et al. (1999).
This 20-item measure with a Likert response format of five
points evaluates the individual’s usual affective state. The
10-item positive affect subscale assess positive affective or
emotional states (e.g., enthusiastic), whereas the 10-item neg-
ative affect subscale assess negative emotional states (e.g.,
scared). Adequate construct validity has been found in studies
that have used this scale in females with FM (Estévez-López
et al., 2016). As reported by the authors of the Spanish version
(Sandin et al., 1999), Cronbach’s alphas of both positive (.89
and .87 for males and females, respectively) and negative (.91
and .89 for males and females, respectively) affect subscale
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were high. Similarly, internal consistency was high for both
positive (.91) and negative affect (.87) in this study.
FM severity was measured using the Spanish adaptation
of the Revised Fibromyalgia Impact Questionnaire (FIQ-R)
developed by Salgueiro et al. (2013), which is composed of
21 items with a numerical response format of 11 points that
evaluate three associated areas: overall impact, physical
function and symptoms. The subscale termed overall im-
pact is composed of 2 items which evaluate to what extent
FM prevented the attainment of objectives or the realization
of plans desired by the person; the subscale named physical
function comprises 9 items or statements that assess the
degree to which difficulties are experienced in doing certain
ordinary physical activities of regular life; and the 10 items
belonging to the subdimension termed symptoms evaluate
the degree to which a variety of symptoms of a diverse
nature (cognitive, emotional, bodily) were experienced.
This scale also allows the computation of a total score
(ranging between 0 and 100), with higher values denoting
greater effect of FM on the individual’s quality of life. The
internal consistency obtained by the three domains ranged
from .81 and .92, and the total score was also reliable (.91 to
.95 with different samples) (Luciano et al., 2013; Salgueiro
et al., 2013), as it was in the present research (.87, .80, .85,
and .92 for physical function, overall impact, symptoms
and the total severity score, respectively).
Analysis
Statistical Package for the Social Sciences (SPSS) version 22
(IBM Corporation, Armonk, USA) was employed for: (i) ex-
amining missing data, (ii) descriptive analyses, (iii)
convergent/divergent validity analyses, and (iv) criterion va-
lidity analyses. EQS version 6.2 (Multivariate Software
Incorporation, Encino, USA) was employed to explore multi-
variate normality and to perform both confirmatory factor
analysis and reliability analysis using structural equation
modeling methodology (SEM). Visual inspection of patterns
of missing data confirmed that such absent values seemed to
be missing completely at random (MCAR), with the overall
amount of missing data equaling less than 5% (1 observation
and 0.4% of missing values) of the sample, confirming that
reliability of the data was not negatively affected (Graham,
2009). In line with Garson's (2012) recommendations, the
one case with missing values was eliminated (listwise dele-
tion), leading to a sample size to 230 participants. The stan-
dardized Mardia’s coefficient of 17.59, showed the data were
not multivariate normal, and therefore robust maximum like-
lihood estimation was used in confirmatory factor analysis
(CFA) (Ullman, 2006).
For the purpose of exploring the CFQ factor structure
(construct validity), CFA was conducted to examine the
configuration presented by the authors who developed the
original scale (Gillanders et al., 2014) and the Spanish ver-
sion for caregivers (Romero-Moreno et al., 2014). The ad-
justment of the model was evaluated using SEM. Although
there are estimation methods such as the diagonally weight-
ed least squares designed specifically to deal with categor-
ical data (Li, 2016), the robust maximum likelihood (MLR)
estimation method has been used in the present study. This
alternative was chosen since other studies support that in
conditions of non-normality and when there are variables
with five or more response alternatives (7 in this case),
these can be treated as if they were continuous and thus
use MLR to evaluate the adjustment of the model
(Raykov, 2012). The selected indexes to assess model fit
were: the scaled chi-square statistic developed by Satorra
and Bentler (1994) (S-B χ 2) with its associated p value and
degrees of freedom (df); the incremental fit index called
Comparative Fit Index (CFI); and the absolute fit index
referred to as Root Mean Square Error of Approximation
(RMSEA), accompanied by its 90% confidence interval
(CI). Considering the sample size below 250 subjects and
the reduced amount of indicators or observed variables, the
adequacy of the model (i.e., good fit) was determined based
on the following cutoff points: S-B χ 2 p value ≥ .05, CFI ≥
.97, and RMSEA ≤ .08 (Hair et al., 2014). To test whether
the modification of a model significantly improves the fit
with respect to the previous model, the S-B χ 2 scaled
difference test (Satorra & Bentler, 2001) was used, with
p value <.05 indicating a better adjustment. Additionally,
the model’s local adjustment was evaluated by both the
standardized factor loadings (λ) and the item’s individual
reliability (R2). Following Hair et al. (2014) and Marôco
(2010), values of λ ≥ .70 and ≥ .50 are considered good
and acceptable, respectively; whilst R2 values ≥ .50 and
≥ .25 are considered good and acceptable, respectively.
Later, the CFA-based scale reliability was assessed.
Since in SEM methodology conventional estimators of in-
ternal consistency (e.g., coefficient alpha) can alter reliabil-
ity, underestimating or overestimating it (Garson, 2012),
and are not considered adequate when error terms are
correlated (Hankins, 2008), internal consistency of the
CFQ was calculated using the Raykov’s Rho coefficient
(frequently known as composite reliability; CR). In line
with Hair et al. (2014) recommendations, CR scores over
.70 are adequate. In those participants who answered the
scale again after two months (n = 62), the intraclass
correlation coefficient (abbreviated as the ICC) was used
to explore test-retest reliability, considering values ≥ .70 as
adequate (Cicchetti, 1994).
Bivariate correlations between the CFQ score and those
variables that were theoretically associated with cognitive fu-
sion (pain catastrophizing, personality traits, positive affect,
and negative affect) were conducted to analyze convergent
and discriminant validity.
Curr Psychol
Finally, multiple linear regression analyses were also per-
formed in order to assess incremental validity, exploring the
independent associations of cognitive fusion with the psycho-
logical outcomes of anxiety and depression, after controlling
for other factors that previously have been shown to contribute
significantly to such outcomes (Haynes & Lench, 2003).
Furthermore, criterion validity was explored by conducting
t-test comparisons in the CFQ score between participants with
mild anxiety/depression or without anxiety/depression (scores
≥11) and those participants with moderate or severe anxiety/
depression (scores <11). Similarly, a t-test was performed to
compare the CFQ score between participants with higher dis-
ease severity (scores >65) and those with moderate or mild
FM severity (scores ≤65). These cut-off points on the severity
of the disease or its mood symptoms have been previously
used in various studies with individuals suffering from FM
(Aparicio et al., 2013; Salaffi et al., 2018) and other conditions
(Zigmond & Snaith, 1983). Cohen’s d (Cohen, 1988) was
computed to analyze the magnitude of these differences, with
values of .20, .50, and .80 representing small, medium, and
large effect sizes, respectively.
Results
Following the proposal of the authors of the original scale and
the Spanish version for caregivers (Gillanders et al., 2014;
Romero-Moreno et al., 2014), the adjustment of a unifactorial
structure made up of the 7 items of the instrument was tested.
The results showed an unsatisfactory fit of this first model (see
Table 2). Factor loadings and communalities of the items were
adequate (λ ranged from .69 to .88 and R2 ranged from .48 to
.78). Modification indices suggested that incorporating a co-
variance between certain item error terms (specifically, be-
tween items 1 and 2) would improve the overall fit of the
model. Even though it is common to employ this procedure
among items belonging to the same factor, it is only justified
when there are substantive theoretical reasons that support it
(Garson, 2012). In this case, previous studies with the CFQ
have correlated both items (“My thoughts cause me distress or
emotional pain” and “I get so caught up in my thoughts that I
am unable to do the things that I most want to do”)
(Lucena-Santos et al., 2017), because they are statements that
refer specifically to thoughts that generate negative conse-
quences for the person (emotional or behavioral limitations,
specifically). Thus, a second one-factor model identical to the
previous one but in which a correlation was added between
the error terms of items 1 and 2 was tested. In this case, the
modified model obtained an excellent fit (see Table 2) and
factor loadings and communalities of the items were adequate
(λ ranged from .66 to .89 and R2 ranged from .43 to .79; see
Fig. 1). After comparing them, the modified model showed a
significantly better fit than the initial model (S-B χ2 scaled
difference = 14.00, df = 1, p < .001).
The internal consistency of the scale was shown to be ex-
cellent in the present sample (CR = .90). The randomly drawn
retest sample was compared to the total sample on the CFQ
and socio-demographic variables and no significant differ-
ences were found. Test-retest reliability in the retest sample
was .71.
Regarding convergent and discriminant validity, the
scale showed significant associations with cognitive vari-
ables linked to pain, with certain personality traits and with
affective variables (see Table 3). Specifically, low magni-
tude correlations were established both with positive affect
and with extraversion and conscientiousness traits;
moderate-low magnitude correlations with disease severity,
depression and pain catastrophizing and its dimensions;
and moderate-high magnitude correlations with neuroti-
cism, negative affect and anxiety. Additionally, the CFQ
average score of the Spanish females with FM (see
Table 3) was higher than those obtained in young adults
in the original article (M = 22.28, SD = 8.30; Gillanders
et al., 2014), in Spanish caregivers of people with dementia
(M = 25.28, SD = 9.68; Romero-Moreno et al., 2014), and
even in Portuguese females with various chronic pain con-
ditions (M = 23.76, SD = 10.83; Carvalho et al., 2019);
being only surpassed by people with mental health difficul-
ties in the original study (M = 34.31, SD = 8.06;
Gillanders et al., 2014).
Incremental validity was explored performing two
multiple linear regression analyses (see Table 4) using
the enter method. The first analysis, with anxiety as
criterion variable, showed that cognitive fusion ex-
plained an additional percentage of variance (3.2%), be-
yond tha t expla ined by neuro t ic i sm and pain
catastrophizing. Using depression as criterion variable,
cognitive fusion also explained a significant amount of
incremental variance (1.5%) over that explained by af-
fect (positive and negative) and pain catastrophizing.
Table 2 Goodness of fit indexes
for the models tested S-B χ
2 df p CFI RMSEA RMSEA 90% CI
One factor 43.265 14 < .001 .960 .095 [.064–.128]
One factor with item 1 and
item 2 correlated errors
15.610 13 .271 .996 .030 [.000–.075]
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In relation to criterion validity, significant differences in
cognitive fusion levels were found between participants with
probable mood or anxiety disorders and those without (see
Table 5). Likewise, there were significant differences in the
CFQ between patients with high FM severity and those with
mild or moderate disease severity. The effect sizes ranged
from medium to large (see Table 5).
Discussion
Cognitive fusion has been shown to be a detrimental cognitive
process that seems to increase vulnerability to various nega-
tive FM outcomes (Carvalho et al., 2018, 2019; Écija et al.,
2020). For this reason, it is of great interest to have sufficiently
solid instruments in the Spanish language that can assess this
process in people with FM.
Although there are cognitive fusion measures specifically
designed for people with chronic pain conditions (Rodero
et al., 2013), it seems that instead of evaluating the degree of
fusion with one’s thoughts, their items rather measure the
individual’s desire or commitment for understanding, fighting
or reducing pain. Thus, this work focuses on the CFQ
(Gillanders et al., 2014) since, in addition to being the most
widely used cognitive fusion instrument (Cincidda et al.,
2019), it is considered more appropriate to evaluate this con-
struct in a general way due to the wide variety of symptoms of
FM, which are not limited exclusively to pain (Häuser et al.,
2015). The Spanish version of the CFQ available to date has
adequate psychometric properties which, however, have been
confirmed in a very specific population and different from that
of patients with chronic pain: caregivers of relatives with de-
mentia (Romero-Moreno et al., 2014). Therefore, this study
aimed to contribute to the field by exploring in depth the
psychometric properties of the CFQ in a sample of Spanish
females with FM.
The present findings show that the Spanish version of the
CFQ (Romero-Moreno et al., 2014) presents adequate psy-
chometric properties, constituting a useful instrument for eval-
uating cognitive fusion in Spanish women with FM. First, the
results of the confirmatory factor analysis supported a
unifactorial structure of the scale, in line with the original
and Span i sh vers ions (Gi l l anders e t a l . , 2014 ;
Romero-Moreno et al., 2014). In particular, similar to the
Brazilian version of the CFQ (Lucena-Santos et al., 2017),
the unifactorial model with a covariance between themeasure-
ment errors of items 1 and 2 obtained an excellent fit. In
addition, factor loadings and communalities of the 7 items
were adequate. The internal consistency of the scale was ex-
cellent and very similar to both the original version
(Gillanders et al., 2014) and the Spanish version in a caregiver
sample (Romero-Moreno et al., 2014), suggesting that the
items provide similar scores when evaluating the construct.
Regarding test-retest reliability, which was not tested in the
aforementioned Spanish version (Romero-Moreno et al.,
Fig. 1 Factor loadings and communalities of the CFQ one-factor struc-
ture with two correlated error terms
Table 3 Descriptives and Pearson correlations (r) between CFQ and
pain catastrophizing, personality traits, affect, anxiety, depression and
disease severity (n = 230)
r p M SD
Cognitive fusion [CFQ] 33.31 9.62
Overall pain catastrophizing [PCS] .45 <.001 31.89 11.65
Rumination [PCS] .37 <.001 10.19 4.05
Magnification [PCS] .41 <.001 6.63 3.09
Helplessness [PCS] .44 <.001 15.06 5.59
Neuroticism [NEO-FFI] .64 <.001 40.02 8.94
Extraversion [NEO-FFI] −.31 <.001 36.40 8.17
Conscientiousness [NEO-FFI] −.20 .003 42.26 6.97
Openness [NEO-FFI] −.08 .234 37.53 6.50
Agreeableness [NEO-FFI] −.10 .888 47.03 5.93
Positive affect [PANAS] −.21 .001 30.83 9.04
Negative affect [PANAS] .64 <.001 29.78 8.53
Anxiety symptoms [HADS] .63 <.001 12.23 3.88
Depressive symptoms [HADS] .50 <.001 9.23 4.29
Disease severity [FIQ-R] .45 <.001 72.37 17.04
Physical function [FIQ-R] .28 <.001 21.30 5.72
Impact [FIQ-R] .40 <.001 13.63 5.35
Symptoms [FIQ-R] .50 <.001 37.43 8.10
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2014), it was adequate, although lower than that reported in
the original scale (Gillanders et al., 2014).
In this study, the CFQ was also revealed as a valid instru-
ment to be used in females with FM. Specifically, the CFQ
showed low-moderate correlations with pain catastrophizing
and its dimensions. This suggests that both are related process-
es, although are sufficiently differentiated to be distinct con-
structs. This is further supported by previous studies that found
that cognitive fusion and the components of catastrophizing
relate differently to different FM outcomes (Écija et al.,
2020). Low negative correlations with extraversion and consci-
entiousness traits were also obtained, as well as moderate-high
negative correlations with neuroticism. Although there is no
prior research that addresses the relationship of cognitive fusion
with Big-Five personality traits, these findings are consistent
with those obtained in patients with diabetes, where a very
similar correlation was found between neuroticism evaluated
in isolation and the CFQ (Momeniarbat et al., 2017). Thus, the
absence of high correlations with personality traits could
indicate that cognitive fusion, despite being a process associat-
ed with individual tendencies (Gillanders et al., 2014), does not
present a conceptual overlap with personality traits. The asso-
ciations found with affective variables were also in the expect-
ed direction (Bolderston et al., 2019), finding correlations of
low and moderate high magnitude with positive affect and
negative affect, respectively. Given that some CFQ items ex-
pressly refer to emotional pain or anger, it is logical to find high
correlations with negative affectivity. Concurrently, and in line
with the previous literature in patients with rheumatic diseases
(Carvalho et al., 2018, 2019; Écija et al., 2020; McCracken
et al., 2014), cognitive fusion was also significantly related to
anxious and depressive symptoms in females with FM. Finally,
the CFQ score was moderately associated with overall disease
severity, supporting the findings of previous studies with a pain
specific instrument of cognitive fusion (Angarita-Osorio et al.,
20192019). Furthermore, the FIQ-R showed low associations
between CFQ and physical functioning and moderate associa-
tions with symptoms and impact of FM. These findings,
Table 4 Multiple linear regression of the independent associations of cognitive fusion with anxiety and depressive symptoms (n = 230)
Anxiety symptoms Depressive symptoms
β p Δ Adj. R2 p β p Δ Adj. R2 p
Predictors Predictors
Step 1 .429 <.001 Step 1
.296
<.001
Neuroticism .657 <.001 Neuroticism .547 <.001
Step 2 .071 <.001 Step 2
.171
<.001
Positive affect −.037 .192 Positive affect −.397 <.001
Negative affect .393 <.001 Negative affect .410 <.001
Step 3 .002 .158 Step 3
.016
.005
Pain catastrophizing .080 .158 Pain catastrophizing .162 .005
Step 4 .032 <.001 Step 4
.015
.006
Cognitive fusion .254 <.001 Cognitive fusion .184 .006
Total adjusted R2 .534 Total adjusted R2
.498
Δ Adj. R2 , change in adjusted R2 with significance levels on F-change
Table 5 Mean differences in
cognitive fusion in participants’
anxiety, depression and severity
status (n = 230)
n Mean SD t p Cohen’s d
Anxious disorder* 155 36.68 7.87 −8.85 <.001 1.25
Non-anxious disorder 75 26.33 9.16
Depressive disorder* 92 37.83 8.14 −6.29 <.001 0.85
Non-depressive disorder 138 30.30 9.36
High FM severity 161 35.29 8.83 −5.26 <.001 0.72
Low-moderate FM severity 69 28.70 9.85
*probable anxious or depressive disorder defined as scoring equal to or above 11 on the HADS subscale (Aparicio
et al., 2013)
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although correlational and not causal, suggest that the degree to
which a person is fused with their thoughts is associated with
increased reporting of bodily, cognitive and emotional symp-
toms and a reduced appraisal of being able to achieve their
goals. All these results underscore the adequate convergent
and discriminant validity of the CFQ with respect to diverse
variables that have been shown to be important in the course
and the involvement of FM.
The Spanish CFQ also exhibits adequate incremental va-
lidity, explaining modest but significant percentages of addi-
tional variance after controlling for well-established variables
in the relationship between FM and anxiety and depression
(Hassett et al., 2008; Malin & Littlejohn, 2012). More specif-
ically, in contrast to a variable that plays a key role in FM such
as pain catastrophizing, cognitive fusion evaluated with the
CFQ manages to explain an additional percentage of variance
of anxiety symptoms, in addition to explaining the same per-
centage of variance of depressive symptomatology as this pain
related variable. In this vein, it has been proposed that people
with pain symptoms that are more fused with their thoughts
would have greater difficulty implementing adaptive coping
strategies in situations that are perceived as threatening
(Luoma et al., 2007). These findings support the idea that, also
in females with FM, psychological distress could be related
not only to the presence and intensity of dysfunctional
thoughts, but also to the degree to which the person fuses with
said thoughts (Romero-Moreno et al., 2014).
Furthermore, it is important to mention that the results of
the present study show that, compared to both the general
population without chronic disease and other chronic pain
populations (Carvalho et al., 2019; Gillanders et al., 2014;
Romero-Moreno et al., 2014), Spanish females with FM seem
to be very fused with their thoughts. Therefore, these results
are in line with the previous evidence about the relevance of
this cognitive process in the course of the disease (Carvalho
et al., 2018, 2019; Écija et al., 2020).
Having shown criterion validity regarding the severity of the
disease and its anxious-depressive symptoms, the CFQ could be
used in clinical practice to identify those patients with FM who
are likely to benefit more from interventions to reduce cognitive
fusion aimed at maximizing living effectively with the disease.
These findings allow future studies to use the Spanish CFQ to
track people’s responses to these psychological interventions
and, in line with previous studies (Trompetter et al., 2015),
conduct larger research trials that shed light on the cognitive
processes that mediate psychological therapies for FM.
The study had several limitations, such as the use of a
non-representative convenience sample of the Spanish popu-
lation with FM. This suggests caution when generalizing the
results of this scale to other population groups or subgroups
(e.g., males with FM). In this vein, despite being a reasonably
minority population (Wolfe et al., 2010), the relatively small
sample size and the use of a single sample to assess the
psychometric properties of the scale should also be highlight-
ed. Thus, we recommend that future studies focus on replicating
the present findings in more diverse samples, and may even
explore the measurement invariance of the scale in different
subgroups (e.g., depending on gender, age, etc.). Another limi-
tation is not having used other general cognitive variables (e.g.,
rumination, experiential avoidance, self-efficacy, etc.) that
would allow a more exhaustive exploration of the discriminant
validity of the CFQ. Furthermore, despite the considerable im-
portance that subjective experience has in pain-related disorders
(Robinson et al., 2013), the use of self-report measures is also a
limitation, since objective and subjective measures often differ
in the study of FM (Munguía-Izquierdo et al., 2019). Finally,
due to the cross-sectional nature of our study, we cannot draw
causal relationships between the assessed variables, so future
longitudinal and experimental studies are necessary.
Despite the aforementioned limitations, the findings of the
present study have a series of relevant implications. On the
one hand, the adequate psychometric properties demonstrated
by the CFQ in females with FM, together with its brevity and
speed of completion, make this scale a very useful instrument
in various types of studies and in clinical work. Therefore, as
the authors of the original version point out, this instrument is
especially suitable for use in initial evaluations in clinical set-
tings, as well as to be employed repeatedly to track changes in
the level of cognitive fusion or associated variables
(Gillanders et al., 2014). On the other hand, and in line with
experimental research in the general population (Masuda
et al., 2010), it could be very useful to practice the ability of
FM patients to distance themselves from their own thoughts
(i.e., cognitive defusion), since this could promote more adap-
tive responses to the situations of psychological distress expe-
rienced daily. In fact, although still scarce, there are interven-
tions developed from ACT that train cognitive defusion in
people with FM that have been shown to produce a significant
improvement in the levels of anxiety, depression and disease
severity (Hughes et al., 2017; Luciano et al., 2014b). In con-
clusion, the CFQ has been revealed as a sufficiently robust and
valid measure in the evaluation of cognitive fusion in Spanish
females suffering from FM, and may also be useful at the
clinical level due to the relationships it has shown with impor-
tant outcomes.
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